期刊文献+

乌拉地尔和尼卡地平治疗高血压急症的比较 被引量:10

Urapidil vs nicardipine in treating hypertensive emergency
在线阅读 下载PDF
导出
摘要 目的:比较乌拉地尔和尼卡地平治疗高血压急症的疗效和不良反应.方法:78例高血压急症病人分为乌拉地尔组和尼卡地平组,每组39例,乌拉地尔组先予12.5~25 mg ,iv,后以4 μg·kg-1·min-1,iv,gtt,根据血压情况调整滴速,最大维持量12 μg·kg-1·min-1.尼卡地平组先予2 mg,iv,然后以1 μg·kg-1·min-1,iv,gtt,根据血压变化调整滴速,最大维持量6 μg·kg-1·min-1.记录用药前后血压、心率等指标的变化.结果:乌拉地尔和尼卡地平组显效、有效和无效分别为36,3,0例和34,4,1例,2组疗效无显著差异(P >0.05),但治疗后乌拉地尔组心率明显下降,尼卡地平组心率明显上升,两者比较差异非常显著(P <0.01);尼卡地平组治疗后最大降压效果出现时间明显迟于乌拉地尔组(P<0.01);心绞痛发作和脑出血加重人数多于乌拉地尔组;不良反应率也高于乌拉地尔组.结论:2种药物治疗高血压急症均效果良好,但乌拉地尔起效更快、应用更安全、适用范围更广. AIM: To compare the therapeutic effects and adverse reactions of urapidil and nicardipine injection in treating hypertensive emergency. METHODS : Seventy-eight patients with hypertensive emergency were randomized into two groups:the urapidil group and the nicardipine group, including 39 ones in each. The former received urapidil 12.5 - 25 mg, iv first, and followed by 4 μg·kg^-1·min^-1 intraven eously with the maximum maintaining does of 12 μg·kg^-1·min^-1 regulated by changes of blood pressure. The latter received nicardipine 2 mg, iv first , and then followed by 1 μg·kg^-1·min^-1 intraveneously with maximum maintaining dose of 6 μg·kg^-1·min^-1 mln regulated according to the changes of blood pressure. Parameters such as blood pressure and heart rate before and after the treatment were recorded. RESULTS: The clinical efficacies including excellent response , response and no response recorded as individual number for urapidil vs nicardipine group were 36, 3,0 vs 34,4,1 respectively with no significant differ- ence between the two groups(P 〉 0.05). The heart rates in urapidil group decreased obviously and those of the nicardipine group increased significantly, showing conspicuous difference (P 〈 0.01 ). The onset with maximum decrease of blood pressure in nicardipine group was inferior to that of urapidil group(P 〈0.01 ). The incidence of angina, aggravation of cerebral bleed- ing and rate of adverse reaction were also high in nicardipine group than those of the urapidil group. CONCLUSION: Intravenous urapidil and nicardipine are both effective in treating hypertensive emergency , buturapidil functions more rapidly, safer and apt to be recommended extensively.
出处 《中国新药与临床杂志》 CAS CSCD 北大核心 2005年第10期795-798,共4页 Chinese Journal of New Drugs and Clinical Remedies
关键词 乌拉地尔 尼卡地平 高血压 急症 urapidil nicardipine hypertension emergencies
作者简介 宋尚明(1964-),男,山东淄博人,副主任医师,博士研究生,主要从事心血管病诊治研究。[联系人]宋尚明。Phn:86-531-793-8911,ext2368。E-mail:shmingsong@163.com
  • 相关文献

参考文献8

二级参考文献28

  • 1赵砚丽.盐酸乌拉地尔辅助体外循环降温[J].新药与临床,1995,14(2):116-117. 被引量:5
  • 2吴端源,施群力,吴奕真,吴顺荣.卡托普利及地尔硫含服治疗高血压急症的疗效观察[J].中国危重病急救医学,1996,8(6):360-361. 被引量:2
  • 3叶平安 朱银南 等.作用于心血管系统的动物.实用麻醉药理学[M].西安:陕西科学技术出版社,1995.630.
  • 4张立生 吴珏 等.骨骼肌松驰药.中国医学百科全书麻醉学[M].上海:上海科学技术出版社,1986.48-50.
  • 5蒋豪 刘俊杰 等.血管扩张药.现代麻醉学(第二版)[M].北京:人民卫生出版社,1997.370.
  • 6金有豫.降血压药[A].陈新谦 金有豫.新编药物学(第14版)[C].北京:人民卫生出版社,1997.280.
  • 7Joint National Committee. The sixth report of Joint National Committee on prevention, detection, evaluation and treatment of high blood pressure[J]. Arch Intern Med, 1997,157(21 ):2 413- 2 419.
  • 8Guidelines Subcommittee. 1999 World Health Organizationinternational Society of Hypertention Guidelines for the manageanent of hypertention[J]. J Hypertens, 1999, 17:151 -183.
  • 9Cherney Straus S.Management of patients with hypertensive urgencies and emergencies:a systematic review of the literature[J].J Gen Intern Med(United States),2002,17(12):937—945.
  • 10Joint national committee on prevention,detection,and treatment of high blood Pressure.The sixth report of the joint national committee on prevention,detection,evaluation,and treatment of high blood pressure[J].Arch Intern Med.1997,157:2413—2446.

共引文献108

同被引文献91

引证文献10

二级引证文献51

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部